Researchers at Vanderbilt University Medical Center are playing a key role in the development of a potential new antiviral drug to treat COVID-19.

The Vanderbilt Vaccine Research Program has received a grant from the NIH to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units.

For a few years, Tennessee has been ranked as one of the highest antibiotic prescribing states in the nation, and a recent study showing that fewer than 2% of clinicians were responsible for prescribing 25% of pediatric antibiotics is moving some to action.

The Vanderbilt Vaccine Research Program (VVRP) has received a grant from the National Institutes of Health (NIH) to continue its work as one of the nation’s nine Vaccine and Treatment Evaluation Units (VTEUs).

The majority of emergency room visits can be averted with a call or visit to a pediatrician

Vanderbilt's Kathryn Edwards, MD, is the recipient of the 2020 John Howland Award, the highest honor given by the American Pediatric Society (APS).

Understanding how RSV is transmitted, which strains dominate and how new strains emerge around the globe will guide better vaccine and anti-viral drug design.